Zhao L - Search Results

1

Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats.

Renard C, Chappey O, Wautier MP, Nagashima M, Lundh E, Morser J, Zhao L, Schmidt AM, Scherrmann JM, Wautier JL. Renard C, et al. Among authors: zhao l. Mol Pharmacol. 1997 Jul;52(1):54-62. doi: 10.1124/mol.52.1.54. Mol Pharmacol. 1997. PMID: 9224812

2

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. Yan SD, et al. Among authors: zhao l. Nature. 1996 Aug 22;382(6593):685-91. doi: 10.1038/382685a0. Nature. 1996. PMID: 8751438

3

Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms.

Zhao L, Morser J, Bajzar L, Nesheim M, Nagashima M. Zhao L, et al. Thromb Haemost. 1998 Dec;80(6):949-55. Thromb Haemost. 1998. PMID: 9869166

4

Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.

Hall SW, Nagashima M, Zhao L, Morser J, Leung LL. Hall SW, et al. Among authors: zhao l. J Biol Chem. 1999 Sep 3;274(36):25510-6. doi: 10.1074/jbc.274.36.25510. J Biol Chem. 1999. PMID: 10464282 Free article.

5

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P. Nagashima M, et al. Among authors: zhao l. Thromb Res. 2000 May 15;98(4):333-42. doi: 10.1016/s0049-3848(00)00184-5. Thromb Res. 2000. PMID: 10822080

6

Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.

Schneider M, Nagashima M, Knappe S, Zhao L, Morser J, Nesheim M. Schneider M, et al. Among authors: zhao l. J Biol Chem. 2002 Mar 22;277(12):9944-51. doi: 10.1074/jbc.M111685200. Epub 2002 Jan 10. J Biol Chem. 2002. PMID: 11786552 Free article.

7

Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificity.

Zhao L, Buckman B, Seto M, Morser J, Nagashima M. Zhao L, et al. J Biol Chem. 2003 Aug 22;278(34):32359-66. doi: 10.1074/jbc.M300803200. Epub 2003 Jun 10. J Biol Chem. 2003. PMID: 12799375 Free article.

8

Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).

Zhao L, Leung LL, Morser J. Zhao L, et al. Methods Mol Biol. 2024;2747:95-117. doi: 10.1007/978-1-0716-3589-6_9. Methods Mol Biol. 2024. PMID: 38038935

9

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.

Nagashima M, Yin ZF, Zhao L, White K, Zhu Y, Lasky N, Halks-Miller M, Broze GJ Jr, Fay WP, Morser J. Nagashima M, et al. Among authors: zhao l. J Clin Invest. 2002 Jan;109(1):101-10. doi: 10.1172/JCI12119. J Clin Invest. 2002. PMID: 11781355 Free PMC article.

10

A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterization.

Wang YX, Zhao L, Nagashima M, Vincelette J, Sukovich D, Li W, Subramanyam B, Yuan S, Emayan K, Islam I, Hrvatin P, Bryant J, Light DR, Vergona R, Morser J, Buckman BO. Wang YX, et al. Among authors: zhao l. Thromb Haemost. 2007 Jan;97(1):45-53. Thromb Haemost. 2007. PMID: 17200770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,934 results

Search Page

Filters